Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patientsA T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 1, 2000
Nanotechnology in bio/clinical analysisG Guetens, K Van Cauwenberghe, G De Boeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic studyH J Groen, E G de Vries, W Wynendaele, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian CancerM E van der Burg, W W ten Bokkel Huinink, R Vriesendorp, et al.
Cancer Research|September 1, 1991
Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiationC M De Pooter, P G Scalliet, H J Elst, et al.
Sarcoma|May 15, 2007
Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patientsG Huygh, Paul M J Clement, H Dumez, et al.
British Journal of Cancer|October 28, 2005
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)S D Fosså, B Paluchowska, A Horwich, et al.
Cancer|May 1, 1984
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma GroupH M Pinedo, V H Bramwell, H T Mouridsen, et al.
Investigational New Drugs|May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumorsM J A de Jonge, J P Droz, L Paz-Ares, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patientsS A Van Der Heyden, M S Highley, E A De Bruijn, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patientsA T van Oosterom, H T Mouridsen, O S Nielsen, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 1, 2000
Nanotechnology in bio/clinical analysisG Guetens, K Van Cauwenberghe, G De Boeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic studyH J Groen, E G de Vries, W Wynendaele, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian CancerM E van der Burg, W W ten Bokkel Huinink, R Vriesendorp, et al.
Cancer Research|September 1, 1991
Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiationC M De Pooter, P G Scalliet, H J Elst, et al.
Sarcoma|May 15, 2007
Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patientsG Huygh, Paul M J Clement, H Dumez, et al.
British Journal of Cancer|October 28, 2005
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)S D Fosså, B Paluchowska, A Horwich, et al.
Cancer|May 1, 1984
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma GroupH M Pinedo, V H Bramwell, H T Mouridsen, et al.
Investigational New Drugs|May 4, 2004
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumorsM J A de Jonge, J P Droz, L Paz-Ares, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patientsS A Van Der Heyden, M S Highley, E A De Bruijn, et al.
Pageof 20